Alumni Companies
Midori's focus on the animal microbiome has many useful purposes from animal welfare to sustainability in the production industry.
GrapheneDx is designing a device that will put the power of the highest performing diagnostics in the palm of your hand and the comfort of your home.
Biobot Analytics analyzes sewage for SARS-CoV-2 nationwide. Their data and analysis gives governments and businesses the tools they need to focus public health efforts and improve lives in the communities they serve.
HiFiBiO provides proprietary single cell technologies for applications in drug and biomarker discovery and development.
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Keya Medical is dedicated to the development and commercialization of deep learning-based medical devices for disease diagnosis and treatment.
I'm a paragraph. Click here to add your own text and edit me. It's easy.
EdiGene is a clinical-stage biotechnology company focused on leveraging cutting-edge genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of genetic diseases and cancer.
Pioneering Medicines is focused on conceiving and developing a unique portfolio of life-changing treatments for patients by leveraging the innovative scientific platforms and technologies within the ecosystem of Flagship Pioneering companies.
Glyde Bio is an immune-oncology startup that are exploiting the aberrantly glycosylated cancer proteome as a new and rich source of tumor neoantigens.
Photys Therapeutics is a proprietary chimeric small molecules platform company, developing a new class of medicines for precise control of protein function.
iNeuro Therapeutics is dedicated to the development of therapeutics for Alzheimer's disease.
![PAQTherapeuticsLogo_FullColor[89]_edited.png](https://static.wixstatic.com/media/eef078_137148ae41bd425d83fd23d6543d8954~mv2.png/v1/fill/w_75,h_25,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/PAQTherapeuticsLogo_FullColor%5B89%5D_edited.png)
PAQ’s global team is pioneering a new approach to restoring health and curing disease through autophagy, the body’s most versatile mechanism for natural cellular degradation.
BioSens8 is a young startup which mines microbes to engineer novel biosensors. They’re first commercializing a progesterone biosensor in order to help women assess their fertility, pregnancy, and menopausal health. However, their underlying platform technology for identifying sensing parts allows them to build biosensors not just for the infertility space, but for various market applications.
Coming soon!
In the News
